Argan, Inc.
AGX
$270.05
-$1.02-0.38%
NYSE
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 237.74M | 193.66M | 232.47M | 257.01M | 227.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 237.74M | 193.66M | 232.47M | 257.01M | 227.02M |
| Cost of Revenue | 193.48M | 156.80M | 186.36M | 212.68M | 195.91M |
| Gross Profit | 44.27M | 36.86M | 46.11M | 44.33M | 31.11M |
| SG&A Expenses | 14.21M | 12.52M | 11.55M | 14.00M | 12.43M |
| Depreciation & Amortization | -- | -- | 1.90M | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 207.69M | 169.32M | 199.81M | 226.68M | 208.34M |
| Operating Income | 30.06M | 24.34M | 32.67M | 30.33M | 18.68M |
| Income Before Tax | 35.64M | 29.79M | 38.63M | 36.98M | 24.28M |
| Income Tax Expenses | 361.00K | 7.24M | 7.26M | 8.97M | 6.08M |
| Earnings from Continuing Operations | 35.28M | 22.55M | 31.37M | 28.01M | 18.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.28M | 22.55M | 31.37M | 28.01M | 18.20M |
| EBIT | 30.06M | 24.34M | 32.67M | 30.33M | 18.68M |
| EBITDA | 30.64M | 24.86M | 33.29M | 30.86M | 19.24M |
| EPS Basic | 2.57 | 1.65 | 2.31 | 2.07 | 1.36 |
| Normalized Basic EPS | 1.62 | 1.37 | 1.78 | 1.71 | 1.13 |
| EPS Diluted | 2.50 | 1.60 | 2.22 | 2.00 | 1.31 |
| Normalized Diluted EPS | 1.58 | 1.32 | 1.71 | 1.65 | 1.09 |
| Average Basic Shares Outstanding | 13.73M | 13.63M | 13.60M | 13.53M | 13.40M |
| Average Diluted Shares Outstanding | 14.13M | 14.11M | 14.14M | 14.03M | 13.88M |
| Dividend Per Share | 0.38 | 0.38 | 0.38 | 0.38 | 0.30 |
| Payout Ratio | 14.68% | 22.48% | 15.96% | 18.55% | 22.22% |